首页> 外文期刊>Journal of Drug Delivery and Therapeutics >FORMULATION AND EVALUATION OF TROPICAMIDE IN-SITU GELS LOADED SOLID LIPID NANOPARTICLES FOR OCULAR DRUG DELIVERY
【24h】

FORMULATION AND EVALUATION OF TROPICAMIDE IN-SITU GELS LOADED SOLID LIPID NANOPARTICLES FOR OCULAR DRUG DELIVERY

机译:眼药交付中对苯二甲酰胺原位装载固体脂质纳米粒的制备与评价

获取原文
获取外文期刊封面目录资料

摘要

The aim of present work Formulation and Evaluation of Tropicamide In-situ Gels loaded Solid Lipid Nanoparticles for Ocular Drug Delivery. The surface morphological of SLN was carried out by TEM. The Tropicamide loaded solid lipid nanoparticles was measured the average particle size was ranges from 182.1+3.12nm to 390.1?±2.10 nm. The zeta potential ranges from -0.17?±1.4 mV to -3.80?±1.5 mV. The entrapment efficiency 66.2 % to 89.2 %. Drug content was ranges from 0.112mg/ml to 0.502 mg/ml. The percentage yield ranges from was ranges from 0.112mg/ml to 0.502 mg/ml. The polydispersity index ranged from 1.011?±0.15 to 1.327?±0.13. These SLN enriched in Chitosan gels the pH of the formulations range from 6.8 to 6.9. The gelling strength ranged from 129 sec to 152 sec. The bioadhesive force was ranges from 10.21 ?±1.15 dynes/cm2 to 15.23 ?± 1.22 dynes/cm2. The viscosity was ranges from 2212 ?± 1.14 cps to 2420?± 1.19 cps. The spreadability coefficient was ranges from 11.2 ?± 1.10 gms/sec to 13.3 ?± 1.21 gms/sec. The in-vitro diffusion release studies carried out at 12 hrs TSLNGF19 shows the 79.2 ?± 0.32. The ex vivo permeation studies for optimized formulation the increased drug permeation and corneal accumulation. In vitro corneal permeation profile of tropicamide loaded SLN from the chitosan gels and commercial eye drop solution (Tropicacyl) across the isolated porcine cornea. The ocular tolerance studies performed with HETCAM assay, corneal hydration study, histopathological studies. The stability studies of chitosan gels for long-term stability as per ICH guidelines (25?°C ?± 2?°C / 60% RH ?± 5% RH) &accelerated stability as per ICH guidelines (40?°C ?± 2?°C / 75% RH ?± 5% RH) there is no changes in gelling strength, bioadhesive force, viscosity, spreadability coefficient in optimized formulation.
机译:当前工作的目的是配制和评估用于眼部药物递送的使用Tropicamide原位凝胶的固体脂质纳米颗粒。 SLN的表面形态通过TEM进行。测定装载有托吡卡胺的固体脂质纳米颗粒的平均粒径为182.1±3.12nm至390.1±2.10nm。 ζ电位的范围为-0.17±1.4mV至-3.80±1.5mV。包封效率为66.2%至89.2%。药物含量为0.112mg / ml至0.502mg / ml。产率百分比范围为0.112mg / ml至0.502mg / ml。多分散指数在1.011≤±0.15至1.327≤±0.13的范围内。这些富含壳聚糖凝胶的SLN制剂的pH值为6.8至6.9。胶凝强度为129秒至152秒。生物粘附力为10.21Ω±1.15达因/ cm 2至15.23Ω±1.22达因/ cm 2。粘度为2212±1.14cps至2420±1.19cps。铺展性系数为11.2Ω±1.10gms / sec至13.3Ω±1.21gms / sec。 TSLNGF19在12小时进行的体外扩散释放研究显示79.2±0.32。用于优化制剂的离体渗透研究增加了药物的渗透和角膜积聚。壳聚糖凝胶和市售滴眼液(Tropicacyl)负载的tropicamide负载的SLN在离体猪角膜上的体外角膜渗透曲线。通过HETCAM分析进行的眼耐受性研究,角膜水化研究,组织病理学研究。根据ICH指南(25?C?±2?°C / 60%RH?±5%RH)的壳聚糖凝胶的长期稳定性的稳定性研究和根据ICH指南(40?C?±2)的加速稳定性?°C / 75%RH?±5%RH)在优化配方中胶凝强度,生物粘附力,粘度,铺展性系数没有变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号